Misonix Gains FDA Clearance for Nexus Ultrasonic Surgical Platform

Misonix received FDA 510(k) clearance to market the Nexus ultrasonic surgical platform. Commercial U.S. launch will commence next month.

Nexus combines all features of the company's existing products, including BoneScalpel, SonicOne and Sonastar, into a single fully-integrated offering driven by a proprietary digital algorithm that results in...

document icon

You are out of free articles for this month

Subscribe as a Guest for $0 and unlock a total of 5 articles per month.

You are out of five articles for this month

Subscribe as an Executive Member for access to unlimited articles, THE ORTHOPAEDIC INDUSTRY ANNUAL REPORT and more.


Julie Vetalice is ORTHOWORLD's Editorial Assistant. She has covered the orthopedic industry for over 20 years, having joined the company in 1999.

Contact Us